Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.42
+0.18 (1.47%)
Mar 10, 2026, 3:04 PM CST

SHE:301211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2017
Cash & Equivalents
544.62543.211,6941,8581,860105.52
Upgrade
Trading Asset Securities
1,0261,094129.4103.98-240
Upgrade
Cash & Short-Term Investments
1,5701,6371,8241,9621,860345.52
Upgrade
Cash Growth
-2.92%-10.26%-7.05%5.50%438.28%-4.77%
Upgrade
Accounts Receivable
56.6375.5375.08127.47161.05114.21
Upgrade
Other Receivables
5.473.82.661.353.092.11
Upgrade
Receivables
62.179.3377.74128.82164.14116.32
Upgrade
Inventory
122.02137.85173.8114.789.5134.59
Upgrade
Other Current Assets
26.6120.6723.5921.2115.677.23
Upgrade
Total Current Assets
1,7811,8752,0992,2272,129603.65
Upgrade
Property, Plant & Equipment
538.35527.75361.99184.8131.7136.76
Upgrade
Long-Term Investments
9.589.64----
Upgrade
Other Intangible Assets
67.3568.9471.0773.2766.6761.45
Upgrade
Long-Term Deferred Tax Assets
2.22.052.192.391.521.38
Upgrade
Long-Term Deferred Charges
2.521.051.33---
Upgrade
Other Long-Term Assets
0.384.6111.0311.471.24-
Upgrade
Total Assets
2,4012,4892,5472,4992,330803.25
Upgrade
Accounts Payable
92.14116.04117.7182.6236.1336.88
Upgrade
Accrued Expenses
11.9714.9912.9211.648.8613.53
Upgrade
Current Portion of Leases
1.091.591.510.97--
Upgrade
Current Income Taxes Payable
1.733.1314.2718.1412.8421.61
Upgrade
Current Unearned Revenue
12.8811.8715.0169.726.3414.03
Upgrade
Other Current Liabilities
7.8416.7613.7325.8238.8413.04
Upgrade
Total Current Liabilities
127.66164.38175.14208.91103.0199.09
Upgrade
Long-Term Leases
2.013.625.156.43--
Upgrade
Long-Term Unearned Revenue
2.012.042.10.220.280.34
Upgrade
Long-Term Deferred Tax Liabilities
10.518.927.496.74.243.43
Upgrade
Total Liabilities
142.19178.97189.89222.26107.53102.85
Upgrade
Common Stock
417.6288288240240180
Upgrade
Additional Paid-In Capital
1,6271,7571,7571,8051,805463.78
Upgrade
Retained Earnings
214.41265.48312.17232.06178.2656.61
Upgrade
Comprehensive Income & Other
0.38-0.3----
Upgrade
Total Common Equity
2,2592,3102,3572,2772,223700.39
Upgrade
Shareholders' Equity
2,2592,3102,3572,2772,223700.39
Upgrade
Total Liabilities & Equity
2,4012,4892,5472,4992,330803.25
Upgrade
Total Debt
3.15.226.667.4--
Upgrade
Net Cash (Debt)
1,5671,6321,8171,9551,860345.52
Upgrade
Net Cash Growth
-2.79%-10.21%-7.04%5.10%438.28%0.79%
Upgrade
Net Cash Per Share
3.753.934.344.715.971.10
Upgrade
Filing Date Shares Outstanding
417.6417.6417.6417.6417.6313.2
Upgrade
Total Common Shares Outstanding
417.6417.6417.6417.6417.6313.2
Upgrade
Working Capital
1,6531,7101,9242,0182,026504.57
Upgrade
Book Value Per Share
5.415.535.645.455.322.24
Upgrade
Tangible Book Value
2,1922,2412,2862,2032,156638.94
Upgrade
Tangible Book Value Per Share
5.255.375.475.285.162.04
Upgrade
Buildings
-257.27114.69107.54103.3696.62
Upgrade
Machinery
-405.47185.73180.96173.8175.42
Upgrade
Construction In Progress
-53.5228.7751.562.17-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.